TY - JOUR AU - Verweij, J. AU - Casali, P. G. AU - Zalcberg, J. AU - LeCesne, A. AU - Reichardt, P. AU - Blay, J. Y. PY - 2004 DA - 2004// TI - Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)17098-0 DO - 10.1016/S0140-6736(04)17098-0 ID - Verweij2004 ER - TY - JOUR AU - Heinrich, M. C. AU - Corless, C. L. AU - Demetri, G. D. AU - Blanke, C. D. AU - Mehren, M. AU - Joensuu, H. PY - 2003 DA - 2003// TI - Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.04.190 DO - 10.1200/JCO.2003.04.190 ID - Heinrich2003 ER - TY - JOUR AU - Heinrich, M. C. AU - Owzar, K. AU - Corles, C. L. PY - 2008 DA - 2008// TI - Correlation of kinase genotype and clinical outcome in the north American intergroup phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by cancer and leukemia group B and Southwest oncology group JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.17.4284 DO - 10.1200/JCO.2008.17.4284 ID - Heinrich2008 ER - TY - JOUR AU - Debiec-Rychter, M. AU - Sciot, R. AU - Cesne, A. AU - Schlemmer, M. AU - Hohenberger, P. AU - Oosterom, A. T. PY - 2006 DA - 2006// TI - KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours JO - Eur J Cancer VL - 42 UR - https://doi.org/10.1016/j.ejca.2006.01.030 DO - 10.1016/j.ejca.2006.01.030 ID - Debiec-Rychter2006 ER - TY - JOUR AU - Heinrich, M. C. AU - Corless, C. L. AU - Blanke, C. D. AU - Demetri, G. D. AU - Joensuu, H. AU - Roberts, P. J. AU - Eisenberg, B. L. AU - Mehren, M. AU - Fletcher, C. D. AU - Sandau, K. AU - McDougall, K. AU - Ou, W. B. AU - Chen, C. J. AU - Fletcher, J. A. PY - 2006 DA - 2006// TI - Molecular correlates of imatinib resistance in gastrointestinal stromal tumors JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.2265 DO - 10.1200/JCO.2006.06.2265 ID - Heinrich2006 ER - TY - JOUR AU - Cassier, P. A. AU - Fumagalli, E. AU - Rutkowski, P. AU - Schöffski, P. AU - Glabbeke, M. AU - Debiec-Rychter, M. PY - 2012 DA - 2012// TI - Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-3025 DO - 10.1158/1078-0432.CCR-11-3025 ID - Cassier2012 ER - TY - JOUR AU - Miranda, C. AU - Nucifora, M. AU - Molinari, F. AU - Conca, E. AU - Anania, M. C. AU - Bordoni, A. PY - 2012 DA - 2012// TI - KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2230 DO - 10.1158/1078-0432.CCR-11-2230 ID - Miranda2012 ER - TY - JOUR AU - Tarn, C. AU - Rink, L. AU - Merkel, E. AU - Flieder, D. AU - Pathak, H. AU - Koumbi, D. PY - 2008 DA - 2008// TI - Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors JO - Proc Natl Acad Sci USA VL - 105 UR - https://doi.org/10.1073/pnas.0803383105 DO - 10.1073/pnas.0803383105 ID - Tarn2008 ER - TY - JOUR AU - Pantaleo, M. A. AU - Astolfi, A. AU - Battista, M. AU - Heinrich, M. C. AU - Paterini, P. AU - Scotlandi, K. PY - 2009 DA - 2009// TI - Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target JO - Int J Cancer VL - 125 UR - https://doi.org/10.1002/ijc.24595 DO - 10.1002/ijc.24595 ID - Pantaleo2009 ER - TY - JOUR AU - Belinsky, M. G. AU - Rink, L. AU - Flieder, D. B. AU - Jahromi, M. S. AU - Schiffman, J. D. AU - Godwin, A. K. AU - Mehren, M. V. PY - 2013 DA - 2013// TI - Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors JO - Genes Chromosom Cancer VL - 52 UR - https://doi.org/10.1002/gcc.22023 DO - 10.1002/gcc.22023 ID - Belinsky2013 ER - TY - JOUR AU - Lasota, J. AU - Wang, Z. AU - Kim, S. Y. AU - Helman, L. AU - Miettinen, M. PY - 2013 DA - 2013// TI - Expression of the receptor for type I insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications JO - Am J Surg Pathol VL - 37 UR - https://doi.org/10.1097/PAS.0b013e3182613c86 DO - 10.1097/PAS.0b013e3182613c86 ID - Lasota2013 ER - TY - JOUR AU - Valadão, M. AU - Braggio, D. AU - Santos, A. F. AU - Pimenta-Inada, H. K. AU - Linhares, E. AU - Gonçalves, R. PY - 2012 DA - 2012// TI - Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients JO - J Surg Res VL - 178 UR - https://doi.org/10.1016/j.jss.2012.03.031 DO - 10.1016/j.jss.2012.03.031 ID - Valadão2012 ER - TY - JOUR AU - Mahadevan, D. AU - Cooke, L. AU - Riley, C. AU - Swart, R. AU - Simons, B. AU - Della Croce, K. PY - 2007 DA - 2007// TI - A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210173 DO - 10.1038/sj.onc.1210173 ID - Mahadevan2007 ER - TY - JOUR AU - Nelson, C. M. AU - Khauv, D. AU - Bissell, M. J. AU - Radisky, D. C. PY - 2008 DA - 2008// TI - Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells JO - J Cell Biochem VL - 105 UR - https://doi.org/10.1002/jcb.21821 DO - 10.1002/jcb.21821 ID - Nelson2008 ER - TY - JOUR AU - Rubió-Casadevall, J. AU - Martinez-Trufero, J. AU - Garcia-Albeniz, X. AU - Calabuig, S. AU - Lopez-Pousa, A. AU - Del Muro, J. G. PY - 2015 DA - 2015// TI - Role of Surgery in Patients with Recurrent,Metastatic, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Sensitive to Imatinib: A Retrospective Analysis of the Spanish Group for Research on Sarcoma (GEIS) JO - Ann Surg Oncol VL - 22 UR - https://doi.org/10.1245/s10434-014-4360-8 DO - 10.1245/s10434-014-4360-8 ID - Rubió-Casadevall2015 ER - TY - JOUR AU - Nannini, M. AU - Biasco, G. AU - Astolfi, A. AU - Pantaleo, M. A. PY - 2013 DA - 2013// TI - An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) JO - J Med Genet VL - 50 UR - https://doi.org/10.1136/jmedgenet-2013-101695 DO - 10.1136/jmedgenet-2013-101695 ID - Nannini2013 ER - TY - JOUR AU - Heinrich, M. C. AU - Griffith, D. AU - McKinley, A. AU - Patterson, J. AU - Presnell, A. AU - Ramachandran, A. AU - Debiec-Rychter, M. PY - 2012 DA - 2012// TI - Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0625 DO - 10.1158/1078-0432.CCR-12-0625 ID - Heinrich2012 ER - TY - JOUR AU - Kang, H. J. AU - Nam, S. W. AU - Kim, H. AU - Rhee, H. AU - Kim, N. G. AU - Kim, H. PY - 2005 DA - 2005// TI - Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208358 DO - 10.1038/sj.onc.1208358 ID - Kang2005 ER - TY - JOUR AU - Matos, P. AU - Jordan, P. PY - 2008 DA - 2008// TI - Increased Rac1b expression sustains colorectal tumor cell survival JO - Mol Cancer Res VL - 6 UR - https://doi.org/10.1158/1541-7786.MCR-08-0008 DO - 10.1158/1541-7786.MCR-08-0008 ID - Matos2008 ER - TY - JOUR AU - Javidi-Sharifi, N. AU - Traer, E. AU - Martinez, J. AU - Gupta, A. AU - Taguchi, T. AU - Dunlap, J. PY - 2015 DA - 2015// TI - Crosstalk between KIT and FGFR3 promotes gastrointestinal stromal tumor cell growth and drug resistance JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-0573 DO - 10.1158/0008-5472.CAN-14-0573 ID - Javidi-Sharifi2015 ER - TY - JOUR AU - Cohen, N. A. AU - Zeng, S. AU - Seifert, A. M. AU - Kim, T. S. AU - Sorenson, E. C. AU - Greer, J. B. PY - 2015 DA - 2015// TI - Pharmacological inhibition of KIT Activates MET signaling in gastrointestinal stromal tumors JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-2564 DO - 10.1158/0008-5472.CAN-14-2564 ID - Cohen2015 ER -